[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:malignant-germ-cell-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Malignant Germ Cell Tumor",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05857969","Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling",[11],"Phase 1","RECRUITING","2026-08-26T02:18:00.873391Z","2026-05-05T02:43:28.220097Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04901702","Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma",[19],"Phase 1\u002FPhase 2","2026-08-26T02:18:32.765187Z","2026-05-05T02:35:31.688370Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT07705035","DBC-664 in Adult Patients With Solid Tumors Associated",[11],"2026-08-26T02:17:43.321968Z","2026-07-19T19:36:05.086969Z",[],[]]